MEDTIDE Inc. has published the full framework for its “2026 Restricted Share Unit Scheme,” a long-term equity incentive plan that will operate for 10 years once approved by shareholders and the Hong Kong Stock Exchange.
Key parameters • Aggregate limit: Total H shares that may be issued, transferred or acquired for all share awards is capped at 10 % of MEDTIDE’s issued share capital on the Adoption Date, equal to 14.18 million shares. • Service-provider sub-limit: Awards to external service providers are limited to 1.42 million shares, or 1 % of issued capital. • Individual ceiling: Grants causing any single participant’s 12-month total to exceed 1 % of outstanding shares require separate shareholder approval. • Scheme term: Awards can be granted until the 10th anniversary of adoption; vesting and settlement may continue beyond that date.
Vesting and funding • Minimum vesting is 12 months from grant acceptance, with narrowly defined exceptions (e.g., “make-whole” awards for new hires, performance-based grants). • Upon vesting, the board may instruct an independent trustee to (i) transfer shares, (ii) sell shares and remit cash at the actual selling price, or (iii) use a combination of both. • Awards can be satisfied with newly issued shares, treasury shares or market purchases funded by company contributions to the trust.
Eligibility and governance • Participants include employees, directors, related-entity staff and qualifying service providers; U.S. residents are excluded until settlement. • RSUs carry no voting or dividend rights before vesting and are non-transferable without Stock Exchange consent. • The board retains full discretion over participant selection, grant terms, performance conditions, waiver of vesting hurdles and settlement method.
Lapse and clawback triggers • Awards automatically lapse if acceptance formalities or vesting conditions are unmet, or if a participant resigns, is dismissed for cause, or becomes an “Excluded Participant.” • The board may claw back vested or unvested awards in cases of fraud, gross misconduct, regulatory breaches, material misstatement of results or other events specified in the scheme. Recovered value may equal the original shares or their cash equivalent.
Adjustments and corporate actions • Formulas are provided to adjust outstanding RSUs for share splits, consolidations, rights issues or capital reductions, ensuring no issue below nominal value. • The board may accelerate vesting in a change-of-control, delisting or winding-up, subject to the 12-month minimum for employee awards.
Termination mechanics • The scheme terminates on the earlier of (i) 10 years from adoption or (ii) a board-resolved early end. Unvested RSUs vest immediately at termination, and residual trust assets are liquidated with net proceeds returned to the company.
Conditions precedent • Implementation requires shareholder approval by special resolution and HKEX listing approval for any new H shares issued under the plan.
Comments